{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:41:34Z","timestamp":1772160094139,"version":"3.50.1"},"reference-count":25,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Otolaryngology"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Identify and summarise the evidence on the efficacy of low\u2010dose verapamil use for adult patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Two reviewers independently searched the data sources until the 28th of December 2023. From 262 studies identified, PRISMA guidelines were implemented to include three randomised controlled trials that used verapamil for patients diagnosed with CRSwNP. Primary endpoints were extracted, including quality\u2010of\u2010life questionnaires and imaging gradings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Across 116 participants, all three studies showed statistically significant improvement in the subjective scores of patients who experienced symptoms in the verapamil group. The mean differences between the two intervention groups and placebo in SNOT\u201022 were \u221219.17 (95% CI: \u221230.76 to \u22127.58) and \u221227.7 (95% CI: \u221249.36 to \u22126.05). On the objective metrics, statistically significant improvement in TNPS or LMS between groups was seen in two out of the three studies (0.01 [\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001], \u22125.2 [\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02]).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although verapamil usage resulted in significant improvements in the subjective and objective measurements of the severity of CRSwNP, the current evidence is insufficient to support widespread usage of verapamil for CRSwNP. Further studies should focus on recruiting a clinically significant number of patients, while ensuring robustness and homogeneity in the methodological design.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/coa.70041","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T19:26:37Z","timestamp":1760556397000},"page":"17-24","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is Verapamil Effective for Treating Patients With Chronic Rhinosinusitis With Nasal Polyps? A Systematic Review"],"prefix":"10.1111","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6602-4724","authenticated-orcid":false,"given":"Fangxing","family":"Yin","sequence":"first","affiliation":[{"name":"School of Medicine and Dentistry Queen Mary University of London  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6846-2562","authenticated-orcid":false,"given":"Haris","family":"Ali","sequence":"additional","affiliation":[{"name":"Medway Hospital  Kent UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4804-3829","authenticated-orcid":false,"given":"Alaa","family":"Abdelhalim","sequence":"additional","affiliation":[{"name":"School of Medicine and Dentistry Queen Mary University of London  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5378-8709","authenticated-orcid":false,"given":"Hassan A.","family":"Elhassan","sequence":"additional","affiliation":[{"name":"Department of ENT Homerton University Hospital Foundation Trust  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072285"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2019.12.007"},{"issue":"29","key":"e_1_2_12_4_1","first-page":"1","article-title":"European Position Paper on Rhinosinusitis and Nasal Polyps 2020","volume":"58","author":"Fokkens W. J.","year":"2020","journal-title":"Rhinology"},{"key":"e_1_2_12_5_1","unstructured":"Systematic Literature Review of the Epidemiology and Clinical Burden of Chronic Rhinosinusitis With Nasal Polyposis accessed November 29 2023 https:\/\/www.tandfonline.com\/doi\/epdf\/10.1080\/03007995.2020.1815682?needAccess=true."},{"key":"e_1_2_12_6_1","volume-title":"International Forum of Allergy & Rhinology","author":"Bleier B. S.","year":"2012"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.11.014"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.2c00943"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535"},{"key":"e_1_2_12_10_1","unstructured":"Chapter\u00a05: Collecting Data accessed January 3 2024 https:\/\/training.cochrane.org\/handbook\/current\/chapter\u201005."},{"issue":"1","key":"e_1_2_12_11_1","first-page":"1005","article-title":"Efficacy of Verapamil in Chronic Rhinosinusitis With Nasal Polyposis: A Double\u2010Blind and Placebo\u2010Controlled Randomized Clinical Trial","volume":"1","author":"Nabavi M.","year":"2022","journal-title":"American Journal of Allergy Asthma and Immunology Research"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.21608\/mjcu.2022.257438"},{"key":"e_1_2_12_13_1","unstructured":"Risk of Bias Tools \u2010 RoB 2 Tool accessed January 3 2024 https:\/\/sites.google.com\/site\/riskofbiastool\/welcome\/rob\u20102\u20100\u2010tool."},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2020.110316"},{"key":"e_1_2_12_15_1","unstructured":"Effect Size Calculator accessed January 23 2024 https:\/\/www.cem.org\/effect\u2010size\u2010calculator."},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.26249"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.26614"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.wjorl.2018.07.002"},{"key":"e_1_2_12_19_1","volume-title":"International Forum of Allergy & Rhinology","author":"Bleier B. S.","year":"2016"},{"issue":"2","key":"e_1_2_12_20_1","first-page":"205","article-title":"P\u2010Glycoprotein Inhibition With Verapamil Overcomes Mometasone Resistance in Chronic Sinusitis With Nasal Polyps","volume":"59","author":"Taha M. S.","year":"2021","journal-title":"Rhinology Journal"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.21361"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.25.393"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2015.04.029"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1750251"},{"key":"e_1_2_12_25_1","volume-title":"Verapamil Hydrochloride | Drugs | BNF Content","year":"2024"},{"issue":"10","key":"e_1_2_12_26_1","first-page":"21","article-title":"Estimating the Size of Treatment Effects","volume":"6","author":"McGough J. J.","year":"2009","journal-title":"Psychiatry (Edgmont)"}],"container-title":["Clinical Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/coa.70041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T10:49:02Z","timestamp":1765795742000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/coa.70041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1111\/coa.70041"],"URL":"https:\/\/doi.org\/10.1111\/coa.70041","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/COA.70041\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/COA.70041\/v3\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/COA.70041\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/COA.70041\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/COA.70041\/v3\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/COA.70041\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/COA.70041\/v3\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/COA.70041\/v1\/review1","asserted-by":"object"}]},"ISSN":["1749-4478","1749-4486"],"issn-type":[{"value":"1749-4478","type":"print"},{"value":"1749-4486","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"2024-12-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}